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Abstract
Interactions between individual members of the B-cell lymphoma 2 (Bcl-2) family of proteins form a regulatory network governing
mitochondrial outer membrane permeabilization (MOMP). Bcl-2 family initiated MOMP causes release of the inter-membrane
pro-apoptotic proteins to cytosol and creates a cytosolic environment suitable for the executionary phase of apoptosis. Using
mathematical modeling and computational simulation, we have analyzed the response of this regulatory network caused by the
up-/downregulation of each individual member of the Bcl-2 family. As a result, a non-linear stimulus-response emerged, the
characteristics of which are associated with bistability and switch-like behavior. Using the principal component analysis (PCA) we
have shown that the Bcl-2 family classifies the random combinations of inputs into two distinct classes, and responds to these by
one of the two qualitatively distinct outputs. As we showed, the emergence of this behavior requires specific organization of the
interactions between particular Bcl-2 proteins.
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Introduction
Programmed cell death (PCD), often denoted as a cellular
suicide, plays an important role in the homeostasis of every
multi-cellular organism [1]. One of the main forms of PCD is
called apoptosis [2, 3, 1], a process which is well distinguished
by its characteristic morphology [4]. Defects in apoptosis reg-
ulation may cause a variety of serious diseases, including the
neurodegenerative disorders [5], autoimmune diseases [6], or
cancer [7, 8, 9]. Apoptosis can be initiated by either extra-
cellular stimuli or by signals originating from a cell’s internal
space [10, 9]. Signals initiating apoptosis then proceed through
the apoptotic signaling pathways, which contain several con-
trol points [10, 9]. One of the most important of such points,
integrating a multitude of incoming apoptotic (and antiapop-
totic) signals is formed by a family of Bcl-2 (B-cell lymphoma
2) proteins [11, 12]. The Bcl-2 family controls mitochondrial
outer membrane permeabilization (MOMP) [13, 14], the crucial
event of apoptosis.
MOMP allows the release of key apoptotic players -
Smac/DIABLO and cytochrome c, from a mitochondrial in-
termembrane space to cytosol [13, 14]. In the presence of
ATP, released cytochrome c binds to a cytosolic protein Apaf-
1, causing Apaf-1 oligomerization and recruitment of an inac-
tive pro-caspase-9, leading to formation of a multi-protein com-
plex known as an apoptosome [15, 16, 17]. Within the apop-
tosome, pro-caspase-9 subsequently undergoes processing and
activation [15, 16, 17]. The active caspase-9 proteolytically ac-
tivates caspase-3 [18]. Smac/DIABLO, once released to the cy-
tosol, inhibits XIAP (X-linked inhibitor of apoptosis) - the most
prominent suppressor of caspases-3 and -9 [19]. Caspase-3 and
other effector caspases (caspases-6 and -7) are the primary ex-
ecutioners of the apoptosis [20, 9]. Activation of effector cas-
pases signifies the point of no-return, after which apoptosis ir-
reversibly occurs [21].
Bcl-2 family members are functionally classified as either an-
tiapoptotic, or proapoptotic. Structurally, Bcl-2 proteins can
be categorized according to the number of Bcl-2 homology
domains (BH) in their α-helical regions [22, 9]. Antiapop-
totic members (Mcl-1, A1, Bcl-xL, Bcl-2, Bcl-w and Bcl-B)
are characterized by the presence of four BH domains (BH1-
4) [23, 24]. Their role is to prevent MOMP by inhibition of
proapoptotic family members [23, 24]. Proapoptotic members
can be divided to BH3-only proteins and multidomain proteins
- effectors [9]. BH3-only proteins can be further subdivided
based on their role in apoptotic signaling. BH3-only subgroup
members, termed sensitizers, or enablers (Noxa, Bad, Puma,
Hrk, Bmf and Bik) can only bind to antiapoptotic Bcl-2 pro-
teins, forming inactive dimers [22]. Members of another BH3
subgroup, termed activators (Bim and Bid), can act in the same
way [22], but in addition, activators can directly activate effec-
tors [23, 25]. Effectors, once activated, undergo oligomeriza-
tion and form pores – mitochondrial apoptosis channels (MAC)
in the mitochondrial outer membrane (MOM), leading eventu-
ally to MOMP. [26, 14]. Therefore, effectors are the primary
target of inhibition by their antiapoptotic relatives [25].
Individual Bcl-2 family members are regulated by wide-
variety of factors, e.g. growth factor deprivation, cytokine with-
drawal, heat shock, DNA damage, hypoxia, death receptors
stimulation and many others [23]. Mechanisms of regulation
include transcription control and/or post-translational modifi-
cations by phosporylation, or proteolytic cleavage [23]. Bcl-2
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family thus integrates a multitude of converging signals to de-
cide whether to commit MOMP or not. This decision is carried
in an all or nothing manner, giving no possibility of intermedi-
ate MOMP. This interesting behavior has made the Bcl-2 family
an attractive subject of mathematical modeling and computer
simulations.
There are several works regarding modeling and simulation
of the Bcl-2 family and the control of MOMP, revealing and
examining a variety of non-linear system behaviors such as ro-
bustness, stimulus-response ultrasensitivity [27] and steady-
state bistability [28, 29, 30]. Besides these, the Bcl-2 family
was involved in several other, more general models of apopto-
sis signaling [31, 32, 33].
In the above mentioned works, the authors reduce the com-
plexity of their model by grouping of several functionally sim-
ilar species together. Usually, the Bcl-2 family’s members
are assigned into four groups according to their structural and
functional classification. The most prominent group’s member
is taken as the model’s representation of the whole group of
species. Previous models of the Bcl-2 regulatory network differ
by level of details, nevertheless they all adopt such simplifica-
tion. Although, such simplification provides an attractive trade-
off between the model’s complexity and plausibility, functional
specificities of Bcl-2 family’s individuals are being omitted.
In the proposed work we provide a literature-based mathe-
matical model in which interactions between individual Bcl-
2 family members are distinguished. Our goal was to in-
vestigate the behavior of the detailed model, in particular to
prove/disprove the switching properties obtained by models
based on functional grouping. In the process we obtained ad-
ditional insight into the decision mechanism of the Bcl-2 con-
trol of MOMP. The non-trivial pattern-recognition emerged as a
consequence of functional specificities of Bcl-2 family individ-
uals. In addition, an explicit model of pair interactions allowed
us to probe the pro- and anti-apoptotic potency of individual
members of the Bcl-2 family and to rank them according to
their ability to promote or prevent the MOMP event.
Results
Bistability of the Bcl-2 family regulation of MOMP
Several previous works [28, 29, 30] have been focused on
the analysis of bistable behavior of the Bcl-2 family mediated
regulation of MOMP. Similarly, we performed a variation of
the single stimulus parameter of the model to analyze steady
state stimulus-response of the model. The production rate of
the tBid (kptBid) was considered as the stimulus and the steady
state concentration of the MAC (MACss) was the measure of
response. The stimulus – kptBid was varied through the cho-
sen range of values, while the other parameters of the model
remained unchanged.
Using the parameters of the model listed in the Table 3 we
have obtained the stimulus-response dependence depicted in the
figure 1. The obtained steady state stimulus-response forms
hysteresis, the typical hallmark of bistability of the dynamic
system. The two thresholds (Fig 1, marked by the left and right
vertical dashed lines) enclose the bistable region. Within the
bistable region, the system under the same value of the stimu-
lus may occur in one of two stable steady states, depending on
the initial conditions. These steady states are separated by the
unstable steady states (marked by dashed curve). Such systems
are often described as the mechanism of a “toggle switch”[34].
Previous works limited themselves to the response of the Bcl-
2 family induced by activators tBid/Bim solely. In the presented
work we have explored the model’s response to variation of
all components, including both activators, all the anti-apoptotic
proteins, enablers and effectors. Utilizing individual production
rates as the input stimuli, we performed set of analyses analo-
gous to the previous one.
In addition to tBid, we have observed that steady state
stimulus-response hysteresis resulted also from stimulation by
the second of activators – Bim (data not shown), as well as by
the the anti-apoptotic proteins. Surprisingly, even a variation of
the production rates of enablers Puma and Bad & Bmf yields
stimulus-response hysteresis (see Fig 2).
Variation of the Hrk & Bik productions yields hysteresis as
well, but the obtained range of bistability is extremely nar-
row, close to ultrasensitive sigmoid curve. Similarly to bista-
bility, sigmoid curve means that modeled system is insensi-
tive to low levels of the given input, but it can respond sig-
nificantly to its high levels. In contrast to bistability, sigmoidal
response is not discretized, as the response is continuously in-
creasing/decreasing with the growing/reducing input strength.
While the bistability can be compared to mechanism of “tog-
gle switch” sigmoid stimulus-response is often compared to the
functioning of the “push-button” [34].
Robust hysteresis with a wide bistable region was yielded
by the variation of production rate of Bax and less pronounced
hysteresis was obtained by variation of production of Bak. This
shows that “toggle” switching of the Bcl-2 response can also be
achieved by significant upregulation of the effector proteins.
Interestingly, variation of the production rate of the Noxa
produced a hyperbolic response. Hyperbolic dependence, in
contrast to hysteresis and sigmoid response, indicates sensitiv-
ity to even a small increase of input stimuli. Therefore, stimu-
lation of the model through the production of Noxa can “tune”
the model’s sensitivity to other incoming stimuli (see Fig 3).
Monte-Carlo variation of production rates results in bimodal
distribution of steady-state abundance of MAC
In the previous section, we analyzed the dependence of the
steady state concentration of MAC on the production of individ-
ual proteins. In what follows, we performed Monte-Carlo anal-
ysis of the dependence of the steady state concentration of MAC
on the simultaneous variation of multiple production rates.
In each iteration, the values of all the production rates
(kpMcl1, kpA1, kpBclXl, kpBcl2, kpBclw, kpBclB, kpHrk, kp-
Bik, kptBid, kpPuma, kpBim, kpBad, kpBmf, kpNoxa, kpBax,
kpBak) of the model were varied according to following rule:
kp = kp∗ · 10q (1)
where kp is the variated production rate, kp∗ is its default value
and q is the random, uniformly distributed real number chosen
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from 〈−2, 2〉 interval. Other parameters of the model were kept
at their default values. Similar to the analysis of bistability, the
steady state concentration of MAC, was used as the output.
We have plotted the distribution of the model’s response ob-
tained for 104 iterations. The results (see Fig. 4) show clear bi-
modal distribution of the model’s response. The bimodal distri-
bution of the response proves that the Bcl-2 regulatory network
can turn random combinations of inputs into two qualitatively
distinct outputs [35, 36, 37, 29].
The minimum located between the local maxima of the re-
sponse distribution (Fig 4, marked by vertical dashed line) was
considered as the threshold value of steady state concentration
of MAC, separating the pro-survival (colored blue) and MOMP
(colored red) responses. Hereafter, the steady state concentra-
tions of the MAC below this threshold are considered as pro–
survival, while the concentrations above the threshold are con-
sidered as MOMP initiating (pro–MOMP). It is worth mention-
ing, that the value of the threshold intersects all the hysteresis
curves (Fig 1 and 2), within the bistable range. The value of this
threshold – ∼ 350, assumes that MOMP occurs once the num-
ber of effector dimers in mitochondria surrounding environment
exceeds 350. This is remarkably good agreement with experi-
mental estimations made by Martinez-Caballero et al. [38].
Bcl–2 family performs non-trivial pattern recognition.
Using the same sets of the production rates as were used in
the previous analysis we arranged the matrix of stimuli. Each
row of this matrix – stimuli vector corresponds to one iteration
of the Monte-Carlo analysis from the previous section and each
of its columns corresponds to the one of the production rates,
defining the size of the stimuli matrix to 104 ×16. Each column
was normalized to its mean. Then we performed the principal
component analysis (PCA) of the matrix of stimuli and plotted
the input vectors within the plane defined by principal compo-
nents.
The results (see Fig 5, left) show that when the random in-
put stimuli vectors are plotted in the PCA–defined plane, they
form a randomly scattered cloud. But, when the each vector
is colored based on the associated response, it appears that the
stimuli associated with the given response are clustered. This
shows, that the Bcl-2 regulatory network is capable of taking
a wide range of random combinations of incoming signals and
classifying them into two sharply defined responses of distinct
biological relevance. Such functionality defines what is in the
field of machine learning and neural networks known as non-
trivial pattern recognition [39, 40, 41, 42].
In following, we created ten alternative models of the Bcl-
2 family, by mutating the topology of the default model. By
mutation we mean random addition of non-existing or deletion
of existing inhibitory interactions between anti-apoptotic and
pro-apoptotic proteins and/or activations of effectors by activa-
tors. Such mutations allow alteration of the Bcl-2 family model
on its detailed level, but preserve the interactions between the
functional groups consistent with the default model.
For each of the alternative models we have performed a to-
tal of five of such mutations. We then performed Monte-Carlo
analysis of these models by generating the 104 random com-
binations of input stimuli. For each alternative model we then
identified the threshold value of the effectors activity and sub-
sequently performed the PCA of the stimuli matrix.
As a result we have found that all the alternative models pro-
duced bimodal distribution of response, but none of them clus-
tered input stimuli similarly to the default model (see Fig 5,
right side). This indicate that, while the bistability can emerge
from alternative topologies of the Bcl-2 family interaction net-
work, the pattern recognition is strictly associated with this par-
ticular topology of this regulatory network.
Pivotal pro- and anti-apoptotic Bcl-2 family members
In the following we wanted to answer the naturally arising
question: Which of the production rates are pivotal regarding
the determination of the model’s response?
The model’s response varies over several orders of magni-
tude. However, all the response values below/above the thresh-
old, regardless of the value itself, are considered to be quali-
tatively equal – pro–survival/pro–MOMP, providing the same
biological consequences. Therefore, we were interested in cor-
relation of the values of the production rates with the response
quality (pro–survival/pro–MOMP), instead of the correlation
with the response quantity.
We utilized the point-biserial correlation coefficient (PBCC)
- rpb as the the measure of the correlation between the value of
the production rate and quality of the model’s response (pro–
survival/ pro–MOMP). PBCC is frequently used to measure
the correlation between the two variables, one of which is di-
chotomous (either naturally, or artificially dichotomized) [43].
PBCC for each production rate was calculated as follows:
rpb =
M − S
σ
√
nM · nS
n2
, (2)
where the M and S are the means of values of the given pro-
duction rate corresponding to pro–MOMP and pro–survival re-
sponses respectively. nM and nS are the number of values of the
given production rate, corresponding to pro–MOMP and pro-
survival responses respectively. n is the total number of the
values of the given production rate and σ is its standard devia-
tion.
The results we obtained (figure 6) prove the role of the tBid
and Bim – the only activators of effectors – as the primary pro-
apoptotic proteins. Similarly, the Puma is the most efficient
MOMP promoter among the enabler proteins. On the other
hand, the most efficient MOMP preventers are proteins A1 and
Bcl-Xl, followed by Mcl-1 and Bcl-w.
Discussion
The Bcl-2 family of proteins consists of sixteen (excluding
tissue-specific Bcl-2 ovarian killer – Bok) proteins that differ in
their upstream regulation as well as in their interactions with
other family members. We translated current biological knowl-
edge of these interactions into mathematical model, which was
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utilized to study the regulation of the MOMP – crucial apoptotic
event, which is maintained by the Bcl-2 family.
Analysis of the model’s response to variation of productions
of individual proteins, revealed that the system property called
steady-state bistability emerges as a robust feature of the mod-
eled system. Our results indicate that the most of the Bcl-2 pro-
teins can serve as bistable “toggles”, up- or downregulation of
these cause “switching on” the MOMP. Steady-state bistability
is currently being ,,the favorite framework for thinking about
the switch between life and death” [44]. Therefore, the above-
mentioned results were expected. However, we have also found
that other Bcl-2 proteins act as a “push-buttons” – alternative
switching mechanisms with very narrow or missing bistable
range and one of them as a “tuner” of the model’s sensitivity
– upregulation of which results in hyperbolic model’s response.
We have shown that the model is able to process random
combinations of inputs to produce output that has bimodal dis-
tribution. This strongly suggests that orchestration of these
“toggles”, “push-buttons” and “tuners” constitutes a molecu-
lar device whose function is to integrate multitude of incoming,
continuous inputs into binary outcomes. Bimodal distribution
was previously observed by Sun et al [29] in the flow cytometry
of Bax activation as the response to staurosporine treatment of
the HeLa cells population, supporting our finding.
Moreover, our results further suggest that this molecular de-
vice can perform pattern recognition – which is non-trivial
functionality, often associated with neural networks and ma-
chine learning algorithms. This functionality is impaired by
deletion of a relatively small number of reactions, as well as by
addition of artificial interactions, even for interactions which
are consistent with the relationships between the functional
groups of the family.
Measurements of the correlation between the individual sig-
nals and the model’s response predict that the most potent in-
puts of this network are associated with the regulation of activa-
tors tBid and Bim, enabler protein Puma and the anti-apoptotic
sentinels A1, Bcl-Xl, Bcl-w and Mcl-1.
Finally, to outline the directions in which the proposed work
could be extended, we would like to point out the necessity of
utilization of more sophisticated, machine-learning based ap-
proaches to better analyze the synergy of the Bcl-2 family reg-
ulation of MOMP. We believe that its understanding can be cru-
cial in development of novel anti-cancer drugs and/or treatment
of the serious neurodegenerative diseases.
Model and its biological relevance
In the proposed work, we modeled the MOMP regulatory
network formed by the interactions of the members of the Bcl-2
family of proteins (see Table 1). Our model of the Bcl-2 family
is defined by the extensive set of reactions which are listed in
Table 2 and the respective set of reaction rates 3, which were
estimated in accordance with the previously published coarse-
grained models of Bcl-2 family.
In each simulation, the initial abundance of each protein was
either set to zero for a protein that is not produced from external
sources (reactions 46–61), otherwise defined by following rule:
a(t0) =
kp
kdeg
, (3)
setting the initial abundance to balance the production (reac-
tions 46–61) and degradation (catch-all reaction 62) of the
given protein at the initial conditions. Default values of the
reaction rates (listed in the Table 2) were estimated in ac-
cord with previously published models of the Bcl-2 family
[27, 28, 29, 30]. The abundance of the mitochondrial apop-
tosis channels – MACs of the detailed model was calculated
as the sum of the abundances of the aBax∼aBax, aBak∼aBak,
aBax∼aBak dimers.
Protein interactions were modeled using mass action kinet-
ics, translated into a set of ordinary differential equations. The
model was implemented and all the analyses were performed
within Python programming language, by using the PySCes
(Python Simulator for Cellular Systems) [45] module.
Acknowledgments
This work was supported by the Slovak Research and De-
velopment Agency (contracts: APVV-0242-11, SEPO I ITMS
code 26220120024 and SEPO II ITMS code 26220120039) and
Scientific Grant Agency of the Ministry of Education of Slovak
Republic under the grant VEGA-1/4019/07. Authors appreciate
this support.
4
References
[1] L. Ouyang, Z. Shi, S. Zhao, F.-T. Wang, T.-T. Zhou, B. Liu, J.-K. Bao,
Programmed cell death pathways in cancer: a review of apoptosis, au-
tophagy and programmed necrosis, Cell Proliferation 45 (6) (2012) 487–
498.
[2] A. H. Wyllie, ”where, o death, is thy sting?” a brief review of apoptosis
biology, Molecular Neurobiology 42 (2010) 4–9.
[3] E. Ulukava, C. Acilan, Y. Y, Apoptosis: why and how does it occur in
biology?, Cell Biochemistry and Function 29 (2011) 468–80.
[4] S. Elmore, Apoptosis: A review of programmed cell death, Toxicologic
Pathology 35 (2007) 495–516.
[5] M. P. Mattson, Neuronal life-and-death signaling, apoptosis, and neurode-
generative disorders, Antioxidants & Redox Signaling 8.
[6] S. Nagata, Apoptosis and autoimmune diseases, Annals of the New York
Academy of Sciences 1209 (2010) 10–16.
[7] C. Burz, I. Berindan-Neagoe, O. Balacescu, A. Irimie, Apoptosis in can-
cer: Key molecular signaling pathways and therapy targets, Acta Onco-
logica 48 (2009) 811–821.
[8] S. Fulda, Tumor resistance to apoptosis, International Journal of Cancer
124 (2009) 511–515.
[9] A. Strasser, S. Cory, J. M. Adams, Deciphering the rules of programmed
cell death to improve therapy of cancer and other diseases, EMBO Journal
30 (2011) 3667–3683.
[10] A. Strasser, L. O’Connor, V. M. Dixit, Apoptosis signaling, Annual Re-
view of Biochemistry 69 (2000) 217–245.
[11] N. N. Danial, S. J. Korsmeyer, Cell death: Critical control points, Cell
116 (2004) 205–219.
[12] J. E. Chipuk, D. R. Green, How do bcl-2 proteins induce mitochondrial
outer membrane permeabilization?, Trends in Cell Biology 18 (2008)
157–164.
[13] S. W. G. Tait, D. R. Green, Mitochondria and cell death: outer membrane
permeabilization and beyond, Nature Reviews Molecular Cell Biology 11
(2010) 621–632.
[14] T. Landes, J. C. Martinou, Mitochondrial outer membrane permeabiliza-
tion during apoptosis: the role of mitochondrial fission, Biochimica et
Biophysica Acta 1813 (2011) 540–545.
[15] P. D. Mace, S. J. Riedl, Molecular cell death platforms and assemblies,
Current Opinion In Cell Biology 22 (2010) 828–836.
[16] E. Perez-Paya, M. Orzaez, L. Mondragon, D. Wolan, J. A. Wells,
A. Messequer, M. J. Vincent, Molecules that modulate apaf-1 activity,
Medical Research Reviews 31 (2011) 649–675.
[17] A. V. Kulikov, E. S. Shilov, I. A. Mufazalov, V. Gogvadze, S. A. Ne-
dospasov, B. Zhivotinsky, Cytochrome c: the achilles’ heel in apoptosis,
Cellular and Molecular Life Sciences 69 (2012) 1787–1797.
[18] M. L. Wurstle, M. A. Laussmann, M. Rehm, The central role of initiator
caspase-9 in apoptosis signal transduction and the regulation of its acti-
vation and activity on the apoptosome, Experimental Cell Research 318
(2012) 1213–1220.
[19] G. Martinez-Ruiz, V. Maldonado, G. Caballos-Cancino, J. P. Grajeda,
J. Melendez-Zajgla, Role of smac/diablo in cancer progression, Journal
of Experimental & Clinical Cancer Research 27.
[20] M. Olsson, B. Zhivotinsky, Capases and cancer, Cell Death & Differenti-
ation 18 (2011) 1441–1449.
[21] D. R. Green, G. B. Amarate-Mendes, The point of no return: mitochon-
dria, caspases, and the commitment to cell death, Results and Problems
in Cell Differentiation 24 (1999) 45–61.
[22] R. Elkholi, K. V. Floros, J. E. Chipuk, The role of bh3-only proteins in
tumor cell development, signaling, and treatment, Genes Cancer 2.
[23] J. E. Chipuk, T. Moldoveanu, F. Llambi, M. J. Parsons, D. R. Green, The
bcl-2 family reunion, Molecular Cell 37 (2010) 299–310.
[24] W. J. Placzek, J. Wei, S. Kitada, D. Zhai, J. C. Reed, M. Pellecchia, A
survey of the anti-apoptotic bcl-2 subfamily expression in cancer types
provides a platform to predict the efficacy of bcl-2 antagonists in cancer
therapy, Cell Death and Disease 6.
[25] D. Westhpal, G. Dewson, P. E. Czabotar, R. M. Kluck, Molecular biol-
ogy of bax and bak activation and action, Biochimica Biophysica Acta 4
(2011) 521–531.
[26] L. M. Dejean, S. Y. Ryu, S. Martinez-Caballero, O. Teijido, P. M. Peixoto,
K. W. Kinnally, Mac and bcl-2 family proteins conspire in a deadly plot,
Biochimica Biophysica Acta 1797 (2010) 1231–1238.
[27] C. Chen, J. Cui, W. Zhang, P. Shen, Robustness analysis identifies the
plausible model of the bcl-2 apoptotic switch, FEBS Letters 581 (2007)
5143–5150.
[28] J. Cui, C. Chen, H. Lu, T. Sun, P. Shen, Two independent positive feed-
backs and bistability in the bcl-2 apoptotic switch, PLoS ONE 3 (2008)
1469.
[29] T. Sun, X. Lin, Y. Wei, Y. Xu, P. Shen, Evaluating bistability of bax acti-
vation switch, FEBS Letters 584 (2010) 954–960.
[30] T. Tokar, J. Ulicny, Computational study of bcl-2 apoptotic switch, Phys-
ica A 391 (2012) 6212–6225.
[31] E. Z. Bagci, Y. Vodovotz, T. R. Billiar, G. B. Ermentrout, I. Bahar, Bista-
bility in apoptosis: Roles of bax, bcl-2, and mitochondrial permeability
transition pores, Biophysical Journal 90 (2006) 1546–1559.
[32] J. G. Albeck, J. M. Burke, B. B. Aldridge, M. Zhang, D. A. Lauffenburger,
P. K. Sorger, Quantitative analysis of pathways controlling extrinsic apop-
tosis in single cells, Molecular Cell 30 (2008) 11–25.
[33] H. Harrington, K. L. Lo, S. Ghosh, K. Tung, Construction and analysis of
a modular model of caspase activation in apoptosis, Theoretical Biology
and Medical Modelling 90 (2008) 1546–1559.
[34] J. J. Tyson, K. C. Chen, B. Novak, Sniffers, buzzers, toggles and blink-
ers: dynamics of regulatory and signaling pathways in the cell, Current
opinion in cell biology 15 (2003) 221–231.
[35] T. S. Gardner, C. R. Cantor, J. J. Collins, Construction of a genetic toggle
switch in escherichia coli, Current Biology 403 (2000) 339–342.
[36] C. P. Bagowski, J. E. Ferrell Jr., Bistability in the jnk cascade, Current
Biology 11 (2001) 1176–1182.
[37] E. M. Ozbudak, M. Thattai, H. N. Lim, B. I. Shraiman, A. van Oudenaar-
den, Multistability in the lactose utilization network of escherichia coli,
Nature 427 (2004) 737–740.
[38] S. Martinez-Caballero, L. M. Dejean, M. S. Kinnally, K. J. Oh, C. A.
Mannella, K. W. Kinnally, Assembly of the mitochondrial apoptosis-
induced channel, mac, The Journal of Biological Chemistry 284 (2009)
12235–12245.
[39] D. Bray, Protein molecules as computational elements in living cells, Na-
ture 376 (6538) (1995) 307–312.
[40] S. S. Haykin, Neural networks: a comprehensive foundation, Prentice
Hall, 1999.
URL http://books.google.sk/books?id=bX4pAQAAMAAJ
[41] A. K. Jain, R. P. W. Duin, J. Mao, Statistical pattern recognition: A re-
view, IEEE Transactions on pattern analysis and machine intelligence
22 (1).
[42] T. Helikar, J. Konvalina, J. Heidel, J. A. Rogers, Emergent decision-
making in biological signal transduction networks, PNAS 105 (2008)
1913–1918.
[43] R. F. Tate, Correlation between a discrete and a continuous variable.
point-biserial correlation, The Annals of mathematical statistics 25 (1954)
603–607.
[44] S. L. Spencer, P. K. Sorger, Measuring and modeling apoptosis in single
cells, Cell 144 (2011) 926–939.
[45] B. G. Olivier, J. M. Rohwer, J.-H. Hofmeyr, Modelling cellular systems
with pysces, Bioinformatics 21 (2005) 560–561.
[46] L. Chen, S. N. Willis, A. Wei, B. J. Smith, J. I. Fletcher, M. G. Hinds,
P. M. Colman, C. L. Day, J. M. Adams, D. C. S. Huang, Differential
targeting of prosurvival bcl-2 proteins by their bh3-only ligands allows
complementary apoptotic function, Molecular Cell 17 (2005) 393–403.
[47] G. J. P. Rautureau, C. L. Day, M. G. Hinds, The structure of boo/diva
reveals a divergent bcl-2 protein, Proteins 78 (2010) 2181–2186.
[48] F. Hua, M. Cornejo, M. H. Cardone, C. L. Stokes, D. A. Lauffenburger,
Effects of bcl-2 levels on fas signaling-induced caspase-3 activation:
molecular genetic tests of computational model predictions, Journal of
Immunology 175 (2005) 985–995.
[49] P. J. Dlugosz, L. P. Billen, M. G. Annis, W. Zhu, Z. Zhang, J. Lin,
B. Leber, D. W. Andrews, Bcl-2 changes conformation to inhibit bax
oligomerization, The EMBO Journal 25 (2006) 2287–2296.
[50] T. Kuwana, M. R. Mackey, G. Perkins, M. H. Ellisman, M. Latterich,
R. Schneiter, D. R. Green, D. D. Newmeyer, Bid, bax, and lipids coop-
erate to form supramolecular openings in the outer mitochondrial mem-
brane, Cell 111 (2002) 331–342.
[51] T. Kuwana, D. D. Newmeyer, Bcl-2-family proteins and the role of mito-
chondria in apoptosis, Current opinion in cell biology 15 (2003) 691–699.
5
Figure Legends
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Figure 1: Steady state concentration of the MAC (MACss) is plotted as a function of the production rate of tBid (kptBid).
MACss is increasing with increasing value of kptBid. The MACss remains at very low levels (pro-survival – the blue solid curve),
until the production rate exceeds the threshold (right vertical dashed line). Exceeding the threshold value causes sudden increase
of the MACss (onset of MOMP – red solid curve). The subsequent decrease of the production of tBid cause only slow decrease of
MACss, until the another threshold is crossed (left vertical dashed line). Then the MACss suddenly drops back to very low levels.
Vertical dashed lines are enclosing the bistable region. Within this region system can persist in one of the two stable steady states
(solid curves), which are separated by unstable steady states (dashed curve).
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Figure 2: Steady state concentration of the MAC plotted as a function of indicated production rates.
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Figure 3: Steady state concentration of the MAC is plotted as a function of the production rate of Noxa. Hyperbolic curve
indicates response sensitivity to event a small levels of stimulation.
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Figure 4: Distribution of steady state concentrations of MAC produced by 104 random variations of the model’s production
rates. Vertical dashed line denotes the minimum between two local maxima, defining the threshold value of the steady state
concentration of the MAC, distinguishing pro-survival and pro-MOMP responses.
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Figure 5: Scatter plot of all input combinations, plotted in the plane defined by the principal components analysis. Inputs
associated with pro-MOMP response are colored red, remaining inputs are colored blue. The clusterization of inputs according to
response quality is apparent for reference model (a), but obviously absent when altering the model’s topology (b).
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Figure 6: Point-biserial correlation coefficients (rpb) as the measure of correlation between the values of the production rates
and the model’s response.
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Table 1: Interactions between individual members of the Bcl-2 family of proteins.
Group & Binds to & inhibits: Activates: Ref.
Member
Antiapoptotic
proteins:
Mcl-1 Noxa, Bim, Puma, Bax, Bak [46, 9]
Bcl-2 Bad, Bim, Puma, Bmf, Bax [46, 9]
A1 Noxa, Bim, Puma, Bid, Hrk, Bik, Bax, Bak [46, 9]
Bcl-xL Bad, Bim, Puma, Bid, Hrk, Bmf, Bik, Bak, Bax [46, 9]
Bcl-w Bad, Bim, Puma, Bid, Hrk, Bmf, Bik, Bax [46, 9]
Bcl-B Bax [47]
Enablers:
Noxa Mcl-1, A1 [46, 22, 9]
Bad Bcl-xL, Bcl-w, Bcl-2 [46, 22, 9]
Puma Bcl-xL, Bcl-w, Bcl-2, Mcl-1, A1 [46, 22, 9]
Hrk Bcl-xL, Bcl-w, A1 [46]
Bmf Bcl-xL, Bcl-w, Bcl-2 [46, 22]
Bik Bcl-xL, Bcl-w, A1 [46]
Activators:
Bim Bcl-xL, Bcl-w, Bcl-2, Mcl-1, A1 Bax, Bak [46, 22, 9]
tBid Bcl-xL, Bcl-w, A1 Bax, Bak [46, 22]
Effectors:
Bak Bcl-xL, Mcl-1, A1 [22, 9]
Bax Bcl-xL, Bcl-w, Bcl-2, Bcl-B, Mcl-1, A1 [22, 9]
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Table 2: List of reactions of the model of the Bcl–2 family of proteins. Reactions no. 46 – 61 denote production of the
correspondent species, while the reaction no. 62 denotes degradation of all the species of the model.
No. Reaction Forward rate Reverse rate
1 tBid + Bax→ tBid + aBax ka
2 tBid + Bak→ tBid + aBak ka
3 Bim + Bax→ Bim + aBax ka
4 Bim + Bak→ Bim + aBak ka
5 Mcl1 + Puma
Mcl1∼Puma ks km
6 Mcl1 + Bim
Mcl1∼Bim ks km
7 Mcl1 + Noxa
Mcl1∼Noxa ki km
8 A1 + Hrk
 A1∼Hrk ki km
9 A1 + Bik
 A1∼Bik ki km
10 A1 + tBid
 A1∼tBid ks km
11 A1 + Puma
 A1∼Puma ks km
12 A1 + Bim
 A1∼Bim ks km
13 A1 + Noxa
 A1∼Noxa kw km
14 BclXl + Hrk
 BclXl∼Hrk ks km
15 BclXl + Bik
 BclXl∼Bik ki km
16 BclXl + tBid
 BclXl∼tBid ki km
17 BclXl + Puma
 BclXl∼Puma ks km
18 BclXl + Bim
 BclXl∼Bim ks km
19 BclXl + Bad
 BclXl∼Bad ks km
20 BclXl + Bmf
 BclXl∼Bmf ks km
21 Bcl2 + Hrk
 Bcl2∼Hrk kw km
22 Bcl2 + Bik
 Bcl2∼Bik kw km
23 Bcl2 + Puma
 Bcl2∼Puma ks km
24 Bcl2 + Bim
 Bcl2∼Bim ks km
25 Bcl2 + Bad
 Bcl2∼Bad ki km
26 Bcl2 + Bmf
 Bcl2∼Bmf ks km
27 Bclw + Hrk
 Bclw∼Hrk ki km
28 Bclw + Bik
 Bclw∼Bik ki km
29 Bclw + tBid
 Bclw∼tBid ki km
30 Bclw + Puma
 Bclw∼Puma ks km
31 Bclw + Bim
 Bclw∼Bim ks km
32 Bclw + Bad
 Bclw∼Bad ki km
33 Bclw + Bmf
 Bclw∼Bmf ks km
34 Mcl1 + aBax
Mcl1∼aBax ks km
35 Mcl1 + aBak
Mcl1∼aBak ks km
36 A1 + aBax
 A1∼aBax ks km
37 A1 + aBak
 A1∼aBak ks km
38 BclXl + aBax
 BclXl∼aBax ks km
39 BclXl + aBak
 BclXl∼aBak ks km
40 Bcl2 + aBax
 Bcl2∼aBax ks km
41 Bclw + aBax
 Bclw∼aBax ks km
42 BclB + aBax
 BclB∼aBax ks km
43 aBax + aBax
 aBax∼aBax kd km
44 aBak + aBak
 aBak∼aBak kd km
45 aBax + aBak
 aBax∼aBak kd km
46 → Hrk kpHrk
47 → Bik kpBik
48 → tBid kptBid
49 → Puma kpPuma
50 → Bim kpBim
51 → Bad kpBad
52 → Bmf kpBmf
53 → Noxa kpNox
54 →Mcl1 kpMcl1
55 → A1 kpA1
56 → BclXl kpBclXl
57 → Bcl2 kpBcl2
58 → Bclw kpBclw
59 → BclB kpBclB
60 → Bax kpBax
61 → Bak kpBak
62 (All)→ kdeg
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Table 3: Detailed model – list of parameters.
Parameter Default value Ref.
ks 1.0 × 10−4
ki 1.0 × 10−5
kw 1.0 × 10−6
ka 1.0 × 10−4
kd 1.0 × 10−4
km 1.0 × 10−2
kdeg 1.0 × 10−3
kpHrk 1.0 1/6 of 6.0, [48, 49]
kpBik 1.0 1/6 of 6.0, [48, 49]
kptBid 0.1 1/2 of 0.2, [48, 49]
kpPuma 1.0 1/6 of 6.0, [48, 49]
kpBim 0.1 1/2 of 0.2, [48, 49]
kpBad 1.0 1/6 of 6.0, [48, 49]
kpBmf 1.0 1/6 of 6.0, [48, 49]
kpNoxa 1.0 1/6 of 6.0, [48, 49]
kpMcl1 10.0 1/6 of 60.0, [50, 51]
kpA1 10.0 1/6 of 60.0, [50, 51]
kpBclXl 10.0 1/6 of 60.0, [50, 51]
kpBcl2 10.0 1/6 of 60.0, [50, 51]
kpBclw 10.0 1/6 of 60.0, [50, 51]
kpBclB 10.0 1/6 of 60.0, [50, 51]
kpBax 60.0 1/2 of 120.0, [50, 51]
kpBak 60.0 1/2 of 120.0, [50, 51]
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